Advertisement
Screener

Creative Medical Technology Holdings, Inc. (CELZ) Increase (Decrease) in Accounts Receivable

2.8 / 5 stars · 68/120 Roast Me

Creative Medical Technology Holdings, Inc. Increase (Decrease) in Accounts Receivable

Creative Medical Technology Holdings, Inc. (CELZ) reported Increase (Decrease) in Accounts Receivable of $0 for the 12-month period ending 2023-12-31, per its 10-K filed 2024-03-22.

Discontinued › Cash Flow › Operating Activities

us-gaap:IncreaseDecreaseInAccountsReceivable · last filed 2024-03-22

  • Creative Medical Technology Holdings, Inc. increase (decrease) in accounts receivable for the quarter ending 2023-12-31 was $0.00.
  • Creative Medical Technology Holdings, Inc. increase (decrease) in accounts receivable for the quarter ending 2023-09-30 was $0.00.
  • Creative Medical Technology Holdings, Inc. increase (decrease) in accounts receivable for the quarter ending 2023-06-30 was $0.00.
  • Creative Medical Technology Holdings, Inc. increase (decrease) in accounts receivable for the quarter ending 2023-03-31 was $0.00.
  • Creative Medical Technology Holdings, Inc. increase (decrease) in accounts receivable for fiscal 2023 was $0.00.
  • Creative Medical Technology Holdings, Inc. increase (decrease) in accounts receivable for fiscal 2022 was -$2.48K, a 200.00% decline from fiscal 2021.
  • Creative Medical Technology Holdings, Inc. increase (decrease) in accounts receivable for fiscal 2021 was $2.48K, a 55.63% decline from fiscal 2020.
  • Creative Medical Technology Holdings, Inc. increase (decrease) in accounts receivable for fiscal 2020 was $5.60K, a 40.00% increase from fiscal 2019.
Period endIncrease (Decrease) in Accounts Receivable 3 monthIncrease (Decrease) in Accounts Receivable 3 month as first filedIncrease (Decrease) in Accounts Receivable 6 monthIncrease (Decrease) in Accounts Receivable 6 month as first filedIncrease (Decrease) in Accounts Receivable 9 monthIncrease (Decrease) in Accounts Receivable 9 month as first filedIncrease (Decrease) in Accounts Receivable 12 monthIncrease (Decrease) in Accounts Receivable 12 month as first filed
2023-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-22
$0.00
derived: sum of 2 quarters · filed 2024-03-22
$0.00
derived: sum of 3 quarters · filed 2024-03-22
$0.00
10-K · filed 2024-03-22
2023-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14
$0.00
derived: sum of 2 quarters · filed 2023-11-14
$0.00
10-Q · filed 2023-11-14
$0.00
derived: sum of 4 quarters · filed 2024-03-22
2023-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-11
$0.00
10-Q · filed 2023-08-11
$0.00
derived: sum of 3 quarters · filed 2024-03-22
$0.00
derived: sum of 4 quarters · filed 2024-03-22
2023-03-31$0.00
10-Q · filed 2023-05-12
$0.00
derived: sum of 2 quarters · filed 2024-03-22
$0.00
derived: sum of 3 quarters · filed 2024-03-22
$0.00
derived: sum of 4 quarters · filed 2024-03-22
2022-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-22
$0.00
derived: sum of 2 quarters · filed 2024-03-22
$0.00
derived: sum of 3 quarters · filed 2024-03-22
-$2.48K
10-K · filed 2024-03-22
2022-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14
$0.00
derived: sum of 2 quarters · filed 2023-11-14
-$2.48K
10-Q · filed 2023-11-14
$0.00
derived: sum of 4 quarters · filed 2023-11-14
2022-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-11
-$2.48K
10-Q · filed 2023-08-11
$0.00
derived: sum of 3 quarters · filed 2023-08-11
$0.00
derived: sum of 4 quarters · filed 2023-08-11
2022-03-31-$2.48K
10-Q · filed 2023-05-12
$0.00
derived: sum of 2 quarters · filed 2023-05-12
$0.00
derived: sum of 3 quarters · filed 2023-05-12
$0.00
derived: sum of 4 quarters · filed 2023-05-12
2021-12-31$2.48K
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31
$2.48K
derived: sum of 2 quarters · filed 2023-03-31
$2.48K
derived: sum of 3 quarters · filed 2023-03-31
$2.48K
10-K · filed 2023-03-31
-$2.48K
10-K · filed 2022-03-30
2021-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10
$0.00
derived: sum of 2 quarters · filed 2022-11-10
$0.00
10-Q · filed 2022-11-10
$0.00
derived: sum of 4 quarters · filed 2022-11-10
2021-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-12
$0.00
10-Q · filed 2022-08-12
$0.00
derived: sum of 3 quarters · filed 2022-08-12
$1.40K
derived: sum of 4 quarters · filed 2022-08-12
2021-03-31$0.00
10-Q · filed 2022-05-13
$0.00
derived: sum of 2 quarters · filed 2022-05-13
$1.40K
derived: sum of 3 quarters · filed 2022-05-13
$8.40K
derived: sum of 4 quarters · filed 2022-05-13
2020-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-30
$1.40K
derived: sum of 2 quarters · filed 2022-03-30
$8.40K
derived: sum of 3 quarters · filed 2022-03-30
$5.60K
10-K · filed 2022-03-30
2020-09-30$1.40K
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15
$8.40K
derived: sum of 2 quarters · filed 2021-11-15
$5.60K
10-Q · filed 2021-11-15
$24.50K
derived: sum of 4 quarters · filed 2021-11-15
2020-06-30$7.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-16
$4.20K
10-Q · filed 2021-08-16
$23.10K
derived: sum of 3 quarters · filed 2021-08-16
-$400.00
derived: sum of 4 quarters · filed 2021-08-16
2020-03-31-$2.80K
10-Q · filed 2021-05-17
$2.80K
10-Q · filed 2020-05-15
$16.10K
derived: sum of 2 quarters · filed 2021-05-17
-$7.40K
derived: sum of 3 quarters · filed 2021-05-17
$10.64K
derived: sum of 4 quarters · filed 2021-05-17
2019-12-31$18.90K
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-17
-$4.60K
derived: sum of 2 quarters · filed 2021-03-17
$13.44K
derived: sum of 3 quarters · filed 2021-03-17
$4.00K
10-K · filed 2021-03-17
-$4.00K
10-K · filed 2020-04-06
2019-09-30-$23.50K
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-13
-$5.46K
derived: sum of 2 quarters · filed 2020-11-13
-$14.90K
10-Q · filed 2020-11-13
$14.90K
10-Q · filed 2019-11-14
-$19.30K
derived: sum of 4 quarters · filed 2020-11-13
2019-06-30$18.04K
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-14
$8.60K
10-Q · filed 2020-08-14
-$8.60K
10-Q · filed 2019-08-13
$4.20K
derived: sum of 3 quarters · filed 2020-08-14
$13.40K
derived: sum of 4 quarters · filed 2020-08-14
2019-03-31-$9.44K
10-Q · filed 2020-05-15
-$13.84K
derived: sum of 2 quarters · filed 2020-05-15
-$4.64K
derived: sum of 3 quarters · filed 2020-05-15
-$9.44K
derived: sum of 4 quarters · filed 2020-05-15
2018-12-31-$4.40K
derived: 10-K 12 month − 10-Q 9 month · filed 2020-04-06
$4.80K
derived: sum of 2 quarters · filed 2020-04-06
$0.00
derived: sum of 3 quarters · filed 2020-04-06
$4.80K
10-K · filed 2020-04-06
2018-09-30$9.20K
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-14
$4.40K
derived: sum of 2 quarters · filed 2019-11-14
$9.20K
10-Q · filed 2019-11-14
$14.00K
derived: sum of 4 quarters · filed 2019-11-14
2018-06-30-$4.80K
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-13
-$1.00
10-Q · filed 2019-08-13
$4.80K
derived: sum of 3 quarters · filed 2019-08-13
$4.80K
derived: sum of 4 quarters · filed 2019-08-13
2018-03-31$4.80K
10-Q · filed 2019-05-20
$9.60K
derived: sum of 2 quarters · filed 2019-05-20
$9.60K
derived: sum of 3 quarters · filed 2019-05-20
$9.60K
derived: sum of 4 quarters · filed 2019-05-20
2017-12-31$4.80K
derived: 10-K 12 month − 10-Q 9 month · filed 2019-04-01
$4.80K
derived: sum of 2 quarters · filed 2019-04-01
$4.80K
derived: sum of 3 quarters · filed 2019-04-01
$4.80K
10-K · filed 2019-04-01
2017-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-14
$0.00
derived: sum of 2 quarters · filed 2018-11-14
$0.00
10-Q · filed 2018-11-14
2017-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-14
$0.00
10-Q · filed 2018-08-14
2017-03-31$0.00
10-Q · filed 2018-08-03
2016-12-31$0.00
10-K · filed 2018-03-29

Similar stocks

Stock NameCountryMarket CapPE Ratio
AIM ImmunoTech Inc. (AIM)United States$0.006B
CERO THERAPEUTICS HOLDINGS, INC. (CERO)United States$0.007B
PharmaCyte Biotech, Inc. (PMCB)United States$0.005B
TScan Therapeutics, Inc. (TCRX)United States$0.008B-1.23
WINDTREE THERAPEUTICS INC /DE/ (WINT)United States$0.003B-0.32
VivoSim Labs, INC. (VIVS)United States$0.003B
Calidi Biotherapeutics, Inc. (CLDI)United States$0.003B
CURIS INC (CRIS)United States$0.002B-0.05
Senti Biosciences Holdings, Inc. (SNTI)United States$0.011B-0.70
Silexion Therapeutics Corp (SLXN)$0.001B